--- title: "EPAM Q2 2026 Earnings: Margin Expansion Outpaces Revenue Growth" type: "News" locale: "en" url: "https://longbridge.com/en/news/295089162.md" description: "EPAM Systems reported Q2 2026 revenue of $1.415 billion, up 4.5% YoY, with GAAP diluted EPS rising 26.3% to $1.97 due to margin expansion and share buybacks. However, first-half operating cash flow turned negative, and Q3 guidance indicates slower revenue growth of 1.7%. Management cited AI momentum and cost controls for profitability gains, though investors should monitor working capital trends and liquidity impacts from significant repurchases." datetime: "2026-08-06T10:16:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295089162.md) - [en](https://longbridge.com/en/news/295089162.md) - [zh-HK](https://longbridge.com/zh-HK/news/295089162.md) --- # EPAM Q2 2026 Earnings: Margin Expansion Outpaces Revenue Growth EPAM Systems (NYSE: EPAM) reported Q2 2026 revenue of $1.415 billion, up 4.5% year over year, while GAAP diluted EPS increased 26.3% to $1.97 from $1.56. Operating margins expanded on both a GAAP and non-GAAP basis, although first-half operating cash flow turned negative and third-quarter guidance points to slower revenue growth. ## Core Earnings Results For the quarter ended June 30, organic constant-currency revenue increased 3.4%, compared with reported growth of 4.5%. EPAM recorded no inorganic revenue contribution, while currency accounted for the difference between reported and organic growth. Profit increased faster than revenue. GAAP operating income rose 20.4%, net income grew approximately 17.0%, and both reported and adjusted operating margins expanded. Metric Q2 2026 Q2 2025 YoY change Revenue $1.415 billion $1.353 billion +4.5% GAAP operating income $152.2 million $126.5 million +20.4% GAAP operating margin 10.8% 9.3% +1.5 pp Non-GAAP operating income $232.7 million $202.9 million +14.7% Non-GAAP operating margin 16.4% 15.0% +1.4 pp Net income $103.0 million $88.0 million Approx. +17.0% GAAP diluted EPS $1.97 $1.56 +26.3% Non-GAAP diluted EPS $3.38 $2.77 +22.0% ## Operating Leverage and Buybacks Pushed EPS Growth Above Revenue Growth Cost of revenue excluding depreciation and amortization increased approximately 2.2%, slower than the 4.5% increase in revenue. Selling, general and administrative expenses rose approximately 5.9%, but the more moderate growth in cost of revenue helped GAAP operating margin expand by 150 basis points. EPS also benefited from a lower share count. Weighted-average diluted shares declined approximately 7.6% to 52.3 million, helping GAAP EPS grow 26.3% even though net income increased about 17.0%. EPAM repurchased $85.0 million of shares during the quarter and $409.0 million during the first half of 2026. The difference between GAAP and non-GAAP operating income remained material. EPAM excluded $80.4 million of Q2 expenses from adjusted operating income, including approximately $46.4 million of stock-based compensation, $17.6 million of acquired-intangible amortization, and $13.9 million of cost-optimization charges. ## Profitability, Cash Flow, and the Balance Sheet Cash conversion was weaker than reported earnings. EPAM used $38.8 million in operating cash during the first six months of 2026, compared with $77.4 million generated in the same period of 2025, despite recording first-half net income of $185.5 million. The balance sheet shows working-capital movements that are relevant to the cash-flow gap. Trade receivables and contract assets increased by $159.8 million from December 31, 2025, while accrued compensation and benefits declined by $112.3 million. The release did not provide a complete cash-flow statement to attribute the entire difference to specific items. Cash, cash equivalents, and restricted cash fell 39.0% from year-end to $794.3 million. First-half repurchases of $409.0 million were a major disclosed use of capital. Long-term debt remained limited at approximately $25.0 million. ## Earnings Guidance EPAM updated its 2026 outlook, although the release did not include the previous ranges, so the size and direction of the revisions cannot be quantified. The latest guidance implies near-term moderation: Q3 reported revenue growth is expected to be 1.7% at the midpoint, below Q2 growth of 4.5%. Metric Q3 2026 guidance Full-year 2026 guidance Revenue $1.410 billion-$1.425 billion Growth of 3.2%-4.2% Organic constant-currency growth 1.8% at midpoint 2.0%-3.0% GAAP operating margin 11.0%-12.0% 10.5%-11.0% Non-GAAP operating margin 15.5%-16.5% 15.5%-16.0% GAAP diluted EPS $2.33-$2.41 $8.22-$8.38 Non-GAAP diluted EPS $3.38-$3.46 $13.08-$13.24 The full-year outlook assumes reported revenue growth will exceed organic constant-currency growth by 1.2 percentage points, reflecting an expected positive currency effect. ## Management’s View CEO and President Balazs Fejes attributed the quarter’s performance to continued AI-native momentum, profitability improvement, and execution against EPAM’s multi-year strategy. Management is also expanding strategic partnerships and developing what it describes as a forward-deployed engineering organization as part of its commercial transformation. ## Recent Insider Transactions The supplied insider data showed no purchase or sale transactions during the previous six months and total insider holdings of 1.69 million shares. The latest reported transactions were equity awards rather than open-market trades. Date Insider or group Role Transaction Reported value May 21, 2026 Helen Shan, Eugene Roman, Deanne Aguirre, Chandra McMahon, Ronald Vargo, Jill Smart, Karl Robb, Robert Segert, and Richard Mayoras Directors Direct stock award grants $0 each March 31, 2026 Viktar Dvorkin Executive Direct stock award grant $1.035 million These grants do not, by themselves, indicate a change in insiders’ views of the company’s prospects. ## Risks Investors Should Watch - **Revenue growth is expected to moderate in Q3.** Guidance implies 1.7% reported growth and 1.8% organic constant-currency growth at the midpoint, both below Q2 levels. - **Cash generation has diverged from earnings.** First-half operating cash flow was negative even as EPAM remained profitable, making working-capital trends an important area to monitor. - **Repurchases have reduced liquidity.** EPAM spent $409.0 million on buybacks during the first half while cash, cash equivalents, and restricted cash declined by $507.1 million from year-end. - **Adjusted earnings exclude substantial costs.** The $80.4 million gap between Q2 GAAP and non-GAAP operating income included recurring categories such as stock-based compensation as well as restructuring-related and acquisition-related costs. - **Currency supports the current growth outlook.** Full-year reported growth guidance is higher than organic constant-currency guidance, so changes in exchange rates could affect reported results. ## Summary EPAM’s Q2 2026 results combined moderate revenue growth with faster operating-profit and EPS growth, supported by slower growth in cost of revenue and a lower diluted share count. The main offsets were negative first-half operating cash flow, a sizable decline in cash following substantial repurchases, and Q3 guidance that indicates slower growth. Future results will depend on whether EPAM can preserve its improved margins while strengthening cash conversion and sustaining organic demand. Find out more ### Related Stocks - [EPAM.US](https://longbridge.com/en/quote/EPAM.US.md) ## Related News & Research - [EPAM releases Q2 2026 fact sheet detailing revenue growth and profitability metrics](https://longbridge.com/en/news/295088051.md) - [EPAM Q2 GAAP diluted EPS rises 26.3% to $1.97; revenue increases 4.5% to $1.42 billion](https://longbridge.com/en/news/295088155.md) - [Mirae Asset Global Investments Co. Ltd. Cuts Holdings in EPAM Systems, Inc. $EPAM](https://longbridge.com/en/news/295917210.md) - [EPAM (EPAM) To Report Earnings Tomorrow: Here Is What To Expect](https://longbridge.com/en/news/294903392.md) - [EPAM Systems (EPAM) Is Up 17.5% After Massive OpenAI Upskilling Push Is AI Now Central?](https://longbridge.com/en/news/294612713.md)